
Prairie Pharms: Specialized healthcare provider using plant-based extracts for research and care.
Founded with a mission to revolutionize healthcare through plant-based extracts, Prairie Pharms is a leading provider of small molecule plant extracts, particularly focusing on monarda-derived compounds containing thymoquinone. Their core vision is to enhance human health by developing high-quality, lipid-soluble, and cell-permeable products. Prairie Pharms is deeply involved in the research and care of monarda clones, ensuring the highest standards in their offerings.
Notable figures associated with Prairie Pharms include experts in plant-based healthcare and investors focused on sustainable and innovative health solutions. The company has achieved significant milestones in the field of natural health products, becoming a world leader in USA-derived small molecule plant extracts. Their impact is evident in the advancement of natural healthcare options and the promotion of plant-based research, contributing to a healthier world.

Phytomedics

Emerald Health Bioceuticals

Platinum Biosciences

PleoPharma
pleopharma.com

Parnell Pharmaceuticals
parnellpharm.com

Apothékary
apothekary.co
Qwell Pharmaceuticals

Agronomed Pharmaceuticals
agronomed.com

Praetego
praetego.com

Constance Therapeutics

Promiliad Biopharma

FarmaceuticalRx

Pure Green Pharmaceuticals
pgpharma.co

Biopharmaceutical Research

Harvest Direct Enterprises
Companies similar to Prairie Pharms include Phytomedics, Emerald Health Bioceuticals, Platinum Biosciences and PleoPharma.
Prairie Pharms was founded in 2010.
Prairie Pharms' headquarters is located in Clear Lake, IA, US.
Prairie Pharms' most recent funding round was for $455k (USD) in April 2013.
As of Apr 29, 2013, Prairie Pharms has raised a total of $455k (USD).
Prairie Pharms has 5 employees as of Feb 5, 2024.